ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,386Medicare Part D Prescriptions Filled, Including Refills

Rank: 51 out of 1125

$1.47M Total Retail Price of All Prescriptions

Rank: 33 out of 1125

638 Patients Receiving at Least One Drug in Part D
51% Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kentucky
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 638 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

32% of this provider’s 638 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
HYDROCODONE-ACETAMINOPHEN 1,278 641 180 S3 1 1
LISINOPRIL 855 431 140 2 2
LEVOTHYROXINE SODIUM 854 529 118 3 3
OMEPRAZOLE 621 353 109 4 4
GABAPENTIN 570 298 93 5 10
DIAZEPAM 535 269 78 B 6 37
FUROSEMIDE 470 281 90 7 7
LOVASTATIN 452 268 79 8 63
AMLODIPINE BESYLATE 440 319 78 9 6
HYDROCHLOROTHIAZIDE 418 290 65 10 12
METFORMIN HCL 404 216 69 11 8
SIMVASTATIN 389 187 65 12 5
NEXIUM 373 168 71 13 20
METOPROLOL SUCCINATE 337 192 47 14 17
CLOPIDOGREL 333 224 61 15 15
METOPROLOL TARTRATE 322 202 52 16 11
MONTELUKAST SODIUM 310 138 56 17 35
CRESTOR 293 182 51 18 29
IBUPROFEN 290 67 68 19 65
ALPRAZOLAM 290 119 46 B 19 16
ATORVASTATIN CALCIUM 277 152 46 21 9
WARFARIN SODIUM 266 167 25 22 18
PROAIR HFA 246 131 64 23 39
POTASSIUM CHLORIDE 230 163 40 24 14
ZOLPIDEM TARTRATE 206 73 35 25 33
AMOXICILLIN 204 127 136 26 84
PANTOPRAZOLE SODIUM 203 75 44 27 27
RANITIDINE HCL 194 87 38 28 24
FLUTICASONE PROPIONATE 192 97 59 29 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 188 64 29 30 28
SPIRIVA 182 131 31 31 60
TAMSULOSIN HCL 182 125 30 31 34
DIOVAN 181 112 26 33 57
CITALOPRAM HBR 177 62 37 34 19
GEMFIBROZIL 173 84 29 35 113
PRAVASTATIN SODIUM 170 108 39 36 13
LOSARTAN POTASSIUM 168 121 30 37 23
NAPROXEN 162 56 49 38 81
PAROXETINE HCL 160 81 27 39 49
CARVEDILOL 159 107 28 40 26
TRAMADOL HCL 153 80 39 41 31
TRAZODONE HCL 148 41 33 42 36
FENOFIBRATE* 141 72 26 43 55
AMITRIPTYLINE HCL 138 57 20 R 44 51
SUCRALFATE 138 71 32 44 114
CYCLOBENZAPRINE HCL 131 21 30 R 46 73
AVODART 131 90 16 46 186
MIRTAZAPINE 126 87 32 48 62
JANUVIA 123 67 22 49 53
CYMBALTA 122 76 22 50 45
PROMETHAZINE HCL 121 44 38 R 51 72
LANTUS SOLOSTAR 113 84 20 52 101
GLYBURIDE 111 53 18 R 53 90
ZETIA 111 50 17 53 77
AMITIZA 108 53 26 55 214
LANTUS 106 62 24 56 66
TIZANIDINE HCL 105 <11 19 57 74
ISOSORBIDE MONONITRATE ER 103 59 20 58 43
FLUOXETINE HCL 103 33 16 58 48
KLOR-CON M20 102 73 19 60 79
HYDROXYZINE PAMOATE 102 22 24 R 60 163
BUPROPION HCL SR 99 37 17 62 192
PREMARIN 98 52 12 R 63 156
GLIPIZIDE 94 44 18 64 64
ATENOLOL 93 20 17 65 21
LYRICA 92 47 20 66 82
LOSARTAN-HYDROCHLOROTHIAZIDE 92 54 13 66 56
MELOXICAM 91 32 23 68 25
ALLOPURINOL 90 47 14 69 40
LEVOFLOXACIN 86 39 62 70 67
BYSTOLIC 86 71 12 70 118
ROPINIROLE HCL 85 37 16 72 75
VENTOLIN HFA 84 45 25 73 117
AZITHROMYCIN 84 47 69 73 47
ADVAIR DISKUS 83 44 20 75 61
PHENYTOIN SODIUM EXTENDED 83 <11 <11 75 149
VALSARTAN-HYDROCHLOROTHIAZIDE 83 43 15 75 102
SYMBICORT 83 38 13 75 107
SERTRALINE HCL 82 38 24 79 22
METHYLPREDNISOLONE 78 36 62 80 112
ALENDRONATE SODIUM 77 <11 <11 81 50
MECLIZINE HCL 77 59 21 81 115
DOXAZOSIN MESYLATE 74 <11 <11 83 91
FENOFIBRATE* 74 11 14 83 55
DONEPEZIL HCL 74 74 12 83 42
SUBOXONE 73 0 12 S3 86 124
DIGOX 72 <11 <11 87 97
DICLOFENAC SODIUM 70 48 20 88 80
CIPROFLOXACIN HCL 69 48 56 89 68
IRBESARTAN 69 <11 <11 89 197
INSULIN SYRINGE* 66 42 18 91 151
DEXILANT 66 41 17 91 174
VERAPAMIL ER 66 <11 <11 91 122
GLIPIZIDE ER 66 51 11 91 135
LORAZEPAM 65 <11 <11 B 95 30
ESCITALOPRAM OXALATE 64 17 14 96 52
LEVEMIR 64 36 11 96 161
GLIMEPIRIDE 64 <11 <11 96 46
OXYCODONE-ACETAMINOPHEN 63 <11 <11 S2 99 105
FLUCONAZOLE 62 31 36 100 137
LANSOPRAZOLE 62 26 12 100 106
CLONAZEPAM 61 <11 <11 B 102 32
DIVALPROEX SODIUM 61 <11 <11 102 98
CELEBREX 61 32 15 102 83
SPIRONOLACTONE 60 <11 <11 105 78
VENLAFAXINE HCL 59 <11 <11 106 207
PREDNISONE 59 44 11 106 44
PHENOBARBITAL 57 <11 <11 R 108 213
VESICARE 57 <11 <11 108 184
NASONEX 55 21 17 110 225
RAMIPRIL 54 <11 <11 111 93
PIOGLITAZONE HCL 52 <11 <11 R 112 95
SYNTHROID 52 <11 <11 112 71
LOVAZA 51 31 15 114 99
DILTIAZEM 24HR CD 50 <11 <11 115 136
AMLODIPINE BESYLATE-BENAZEPRIL 50 <11 <11 115 85
OXYBUTYNIN CHLORIDE 50 <11 <11 115 150
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.